To strengthen our findings from smaller sample numbers, we analyzed the publicly available prostate cancer patient dataset (Wallace et al., 2008) from Oncomine database and found significantly higher levels of both MTA1 and CTSB in tumor samples compared to normal prostate tissues (Fig. 6C). This evidence concerns the gene MTA1 and neoplasm.